Tirzepatide Elevate your weight loss regimen with Tirzepatide, a dual GLP-1 and GIP agonist that masterfully suppresses hunger while extending fullness
First, we emulated two cardiovascular outcome trials, SUSTAIN-6 (semaglutide versus sitagliptin as placebo proxy) and SURPASS-CVOT (tirzepatide versus dulaglutide), to benchmark and critically evaluate our design, data and analytic framework
Learn more Zepbound is a prescription medicine
Across these studies, weight loss was consistently greater with semaglutide than with placebo, and the weight loss was associated with improvements in cardiometabolic risk factors including blood pressure, waist circumference, lipid profiles, and inflammatory markers
In addition, the price might vary based on whether the pharmacy is an independent local store or part of a larger chain